From: Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning
Colorectal cancer cohort | Pancreatic cancer cohort | ||
---|---|---|---|
n | 47 | 31 | |
Age (median [IQR]) | 65.79 [56.99, 74.62] | 65.39 [56.87, 75.08] | |
Sex (%) | F | 17 (36.2%) | 16 (51.6%) |
M | 30 (63.8%) | 15 (48.4%) | |
T-Stage (%) | T1 | 2 (4.3%) | 1 (3.2%) |
T2 | 4 (8.5%) | 3 (9.7%) | |
T3 | 24 (51.1%) | 6 (19.4%) | |
T4 | 15 (31.9%) | 19 (61.3%) | |
Tx | 2 (4.3%) | 2 (6.5%) | |
N-Stage (%) | N0 | 8 (17.0%) | 6 (19.4%) |
N1 | 18 (38.3%) | 11 (35.5%) | |
N2 | 20 (42.6%) | 14 (45.2%) | |
Nx | 1 (2.1%) | ||
M-Stage (%) | M1 | 47 (100.0%) | 31 (100%) |
Liver lesions | Number | 435 | 861 |
Per patient | 9.25 | 27.77 | |
Mean HU | 45.89 | 44.93 | |
Liver parenchyma | Liver tumor burden | 9.8% | 6.7% |
Mean HU | 91.13 | 86.35 |